Dimethyl 4-nitro-1H-pyrazole-3,5-dicarboxylate, 97%, 1g

Ethyl 2-((tert-butoxycarbonyl)amino)-2-(pyridin-2-yl)acetate, 97.0%, 250mg

Chloromethyl p-tolyl sulfide, 98%, 1g

3-Bromo-5-methylbenzotrifluoride, 99.0%, 5g

1-sec-butyl-3-nitro-1H-pyrazole, 1g

1,2,3,4-Tetrahydroisoquinolin-5-ol hydrobromide, 97%, 250mg

Ethyl 5-hydroxy-2-methyl-1-benzofuran-3-carboxylate, 98+%, 1g

(E)-N-(4-((3,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide (Dacomitinib Impurity), 98%, 50mg

3-chloroimidazo[1,2-a]pyridine-2-carbohydrazide, 1g

(4-Bromobutyl)phosphonic Acid>98.0%(T)1g

Acide pimélique, min 99 %, 25 g, emballage plastique.

3H-Cyclopenta[c]quinoline, 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-, (3aS,4R,9bR)-, 99%, 50mg

trans-1,2-Dithiane-4,5-diol, 95.0%, 10g